The home infusion therapy market consists of revenues generated by entities (organizations, sole traders and partnerships) by providing infusion devices, intravenous administration sets, vascular access products and related support services for the delivery of medications and nutritional products in home care settings. The market includes infusion pumps, intravenous sets, IV cannulas and needleless connectors used for the administration of therapies such as total parenteral nutrition, anti-infective therapy, hydration therapy, chemotherapy and specialty pharmaceutical infusions. These products and services are used by patients receiving care outside hospitals, including in private homes, long-term care facilities and outpatient settings.
The global home infusion therapy market was valued at $22,714.0 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 9.00%.
Rising Prevalence Of Autoimmune Disorders
During the historic period, the home infusion therapy market was mainly driven by the growth of rising prevalence of autoimmune disorders. The increasing number of patients requiring biologics, immunoglobulins and specialty infusion therapies is supporting greater adoption of at-home treatment services. Many individuals need continuous therapy over long periods, making home-based care a more convenient and comfortable option than repeated hospital visits. Healthcare providers are increasingly encouraging remote administration to lower pressure on hospitals and enhance patient quality of life. For instance, in March 2025, according to NIH Office of Autoimmune Disease Research, a US-based government health research authority, indicated that more than 50 million Americans, representing nearly 8% of the U.S. population, were affected by autoimmune diseases. The data further highlighted that the global incidence of autoimmune diseases was increasing by approximately 19.1% annually, with rheumatological autoimmune disorders such as Sjogren's syndrome and lupus rising by around 7.1% per year. Therefore, the home infusion therapy market was mainly driven by the rising prevalence of autoimmune disorders.
Artificial Intelligence And Autonomous Intelligence
Major companies operating in the home infusion therapy market are focusing on AI-driven care management platforms, intelligent workflow automation and data-based decision support systems to improve patient management and operational performance. It combines integrating autonomous digital tools to enhance coordination between providers, pharmacies and patients across home-based infusion services. For instance, in March 2025, Uptiv Health, a U.S.-based healthcare technology company focused on infusion care and care coordination solutions, partnered with Lamar Health, a U.S.-based healthcare AI company specializing in automation and data-driven clinical workflows, to transform infusion care delivery through AI-powered automation. The collaboration aims to streamline infusion therapy operations by integrating intelligent scheduling, patient monitoring and decision-support tools, thereby reducing administrative burden on providers and improving safety, efficiency and patient outcomes across home and outpatient infusion settings.
The global home infusion therapy market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 17.7% of the total market in 2024.
Home Infusion Therapy Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global home infusion therapy market.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is evolving with growth in the number of listed companies, greater focus on ESG and sustainability positioning, increased focus on broadening shareholder base and rising frequency of M&A and corporate restructuring.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for home infusion therapy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The home infusion therapy market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider home infusion therapy market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth: - Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis: - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation: - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by product, by administration, by application and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size And Growth: - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard: - Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments: - Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies: Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations: This section includes recommendations for home infusion therapy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Product: Infusion Pumps; Intravenous Sets; IV Cannulas; Needleless Connectors
- 2) By Administration: Intravenous; Subcutaneous; Epidural; Intramuscular
- 3) By Application: Total Parenteral Nutrition; Anti-Infective Therapy; Hydration Therapy; Chemotherapy; Ivig Or Specialty Pharmaceuticals; Other Applications
- 4) By End User: Patients; Nurse; Other End Users
- Companies Mentioned: Option Care Health Inc; CVS Health Corp; Baxter International Inc; B. Braun Melsungen AG; Fresenius SE
- Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Mexico; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; home infusion therapy indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.